1994 1994: Pharmaceutical Drugs, Intellectual Property Rights and Public Health: A Consumer Perspective from the United States, May 12. A discussion of how R&D mandates can ensure innovation does not suffer when prices lowering policies are embraced. 1996 1996: Comments… Continue Reading
KEI’s timeline of WIPO negotiations on the treaty from 1961 to 2023 is available here. For SCCR 43, March 13 to March 17, 2023 Meeting documents. (link) English version of Second Revised Draft Text for the WIPO Broadcasting Organizations Treaty,prepared… Continue Reading
USDOJ 2017 UPDATE OF THE ANTITRUST GUIDELINES FOR THE LICENSING OF INTELLECTUAL PROPERTY STANDARD SETTING AND COMPETITION November 8, 2012 COMPETITION, INNOVATION AND INTELLECTUAL PROPERTY, April 26, 2012 CHAPTER 6 : COMPETITIVE ISSUES REGARDING PRACTICES THAT EXTEND THE MARKET POWER… Continue Reading
The following is a letter that was sent on November 3, 2009 to President Obama, asking that the negotiations regarding ACTA be made more transparent. For more background on ACTA and the disputes over transparency, see KEI website on ACTA… Continue Reading
The following is a letter that was sent on November 3, 2009 to President Obama, asking that the negotiations regarding ACTA be made more transparent. For more background on ACTA and the disputes over transparency, see KEI website on ACTA… Continue Reading
In the area of Transparency, KEI works on several different topics, including for example: Norm setting. KEI has advocated access to meeting venues, timely disclosures of negotiating texts, and the use of webcasting of meetings, among other measures. Trade negotiations… Continue Reading
On February 9, 2018, the Trump Administration released a paper by the Counsel of Economic Advisers (CEA) on drug pricing. The paper on pricing was thought to have been led by economist Tomas Philipson, appointed to the CEA by President… Continue Reading
High Level Timelines of privileges regarding the commercialization and use of knowledge Timeline of privileges regarding the commercialization and use of knowledge: Part 1: before 1980 Timeline of privileges regarding the commercialization and use of knowledge: Part 2: 1980 to… Continue Reading
(More on compulsory licensing here.) This is a non-exhaustive set of provisions in US statutes that are used to for non-voluntary use of patented inventions. 28 U.S.C. 1498 – Patent and copyright cases (a) Whenever an invention described in and… Continue Reading
The proposed Regional Comprehensive Economic Partnership, known as RCEP. RCEP is a massive proposed trade agreement, some see as a rival or alternative to the TransPacific Partnership (TPP). The RCEP currently involves the ten member states of the Association of… Continue Reading